Shaw T, Smillie R H, MacPhee D G
Department of Microbiology, LaTrobe University, Bundoora, Australia.
Mutat Res. 1988 Jul-Aug;200(1-2):99-116. doi: 10.1016/0027-5107(88)90074-7.
The enzyme thymidine phosphorylase (thymidine: orthophosphate deoxyribosyltransferase, EC 2.4.2.4), which plays a crucial role in nucleic acid metabolism in both prokaryotic and eukaryotic cells by regulating the availability of thymidine, is present in mammalian blood. Here we describe a simple, rapid HPLC-based micromethod for the assay of blood thymidine phosphorylase. We have arbitrarily defined 1 unit of blood thymidine phosphorylase activity as the activity required to produce a 1-nM increment in the plasma concentration of thymine after incubation for 1 h at 37 degrees C with a saturating concentration of exogenous thymidine. In normal adults, whole (peripheral venous) blood thymidine phosphorylase activity with blood cells intact was 64 +/- 11 units (mean +/- S.D., n = 20, range 45-89). The apparent Michaelis constant for thymidine was of the order of 10(-4) M but varied nearly 5-fold between different individuals. Activity increased when blood cells were permeabilised or lysed with non-ionic detergents, implying that thymidine phosphorylase is an intracellular enzyme which may be influenced by exogenous as well as intracellular factors. When blood from normal donors was fractionated, thymidine phosphorylase activity consistently co-isolated with platelets. Whole-blood thymidine phosphorylase activity correlated well with platelet parameters. Although thymidine phosphorylase activity was also detected in plasma and serum, the small size and notorious fragility of platelets suggest its platelet origin. Blood from leukaemic donors showed significantly increased thymidine phosphorylase activity compared to normal controls (mean activity +/- S.D. was 96 +/- 27 units; range 58-140, n = 8). Thymine formation from thymidine was temperature- and pH-dependent in whole blood. 2'-Deoxyuridine and 3 of its 5-halogenated analogues (but not 3'-azido-3'-deoxythymidine (AZT), were catabolised by blood thymidine phosphorylase, even during blood clotting at room temperature. Assumptions about in vivo concentrations of these compounds should therefore be interpreted cautiously. In the presence of high concentrations of thymine and suitable deoxyribose donors, small amounts of thymidine were formed in some blood samples, so it is conceivable that thymidine catabolism may be reversible in vivo under some circumstances.
胸苷磷酸化酶(胸苷:正磷酸脱氧核糖基转移酶,EC 2.4.2.4)通过调节胸苷的可用性在原核细胞和真核细胞的核酸代谢中起关键作用,它存在于哺乳动物血液中。在此,我们描述了一种基于高效液相色谱的简单、快速的微量方法,用于测定血液中的胸苷磷酸化酶。我们任意将1个单位的血液胸苷磷酸化酶活性定义为在37℃下与饱和浓度的外源性胸苷孵育1小时后,使血浆中胸腺嘧啶浓度增加1 nM所需的活性。在正常成年人中,血细胞完整的全血(外周静脉血)胸苷磷酸化酶活性为64±11单位(平均值±标准差,n = 20,范围45 - 89)。胸苷的表观米氏常数约为10⁻⁴ M,但不同个体之间变化近5倍。当血细胞用非离子洗涤剂通透化或裂解时,活性增加,这意味着胸苷磷酸化酶是一种细胞内酶,可能受到外源性和细胞内因素的影响。当对正常供体的血液进行分级分离时,胸苷磷酸化酶活性始终与血小板共分离。全血胸苷磷酸化酶活性与血小板参数密切相关。尽管在血浆和血清中也检测到了胸苷磷酸化酶活性,但血小板体积小且脆弱,这表明其起源于血小板。与正常对照相比,白血病供体的血液显示胸苷磷酸化酶活性显著增加(平均活性±标准差为96±27单位;范围5∼140,n = 8)。全血中由胸苷形成胸腺嘧啶的过程依赖于温度和pH。2'-脱氧尿苷及其5种卤化类似物中的3种(但不包括3'-叠氮-3'-脱氧胸苷(AZT))即使在室温下血液凝固过程中也会被血液胸苷磷酸化酶分解代谢。因此,关于这些化合物体内浓度的假设应谨慎解释。在高浓度胸腺嘧啶和合适的脱氧核糖供体存在的情况下,一些血液样本中会形成少量胸苷,所以可以想象在某些情况下,胸苷分解代谢在体内可能是可逆的。